Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

FORE US Bio Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

F

FORE US Bio Inc.

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

SEC CIK: 0001990659

Founded: 2022Source: [SEC]
Headquarters: PHILADELPHIA, PENNSYLVANIASource: [SEC]
Headcount: 0Source: [SEC]
Stage: Series C
Sector: Healthcare

$70.4MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Overview

FORE US Bio Inc. filed a Form D notice of exempt offering with the SEC.

Funding rounds

1 rounds

Private placement (Form D)Apr 2025Source: [SEC]
$70.4M
—post-money

Investors

No investors recorded yet for FORE US Bio Inc..

Add an investor

People

Leadership

William HinshawExecutive OfficerSince 2026Source: [SEC]

Erez ChimovitsDirectorSince 2026Source: [SEC]

Showing 2 of 8 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Acquisitions

FORE US Bio Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Diversity investments

No diversity signals recorded yet for FORE US Bio Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.